CevipabulinAlternative Names: Cevipabulin fumarate; TAP-237; TTI-237
Latest Information Update: 07 Aug 2009
At a glance
- Originator Wyeth
- Class Antineoplastics; Pyrimidines; Small molecules
- Mechanism of Action Tubulin polymerisation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 21 Sep 2005 Phase-I clinical trials in Solid tumours in USA (IV)